Abstract:Small-for-size graft or small-for-size syndrome (SFSS) has emerged as an important clinical problem. SFSS is associated with high morbidity and poor prognosis, and many questions remain unanswered regarding its pathogenesis and treatment of SFSS (1–5). We report a liver graft recipient who developed clinical evidence of prolonged cholestasis and intractable ascites after a small-for-size right lobe living donor liver transplantation (LDLT) and who was successfully treated with a new procedure: selective splenic artery embolization using an interventional approach. The liver graft weighed 846 g, which was 56% of the recipient’s standard liver graft, and 0.90% of his body weight. After LDLT, serum total bilirubin remained at a high level, and the daily ascitic fluid volume increased to more than 2000 mL. The patient was initially treated with a steroid pulse therapy for possible acute rejection. However, a liver biopsy demonstrated no histologic features of acute rejection. A computed tomography scan showed congestion of liver segments of V and VIII, and both Doppler ultrasonography and a venacavography revealed lack of patency of the anastomosis between V5/V8 and interior vena cava indicating an outflow block of the segment V and VIII anastomosis. The Doppler ultrasonogram also showed that the portal vein system was dilated and with a very high flow velocity in the portal vein (60–70 cm/s), indicating portal overperfusion. The liver biopsy was also consistent with portal overperfusion liver injury. Our new procedure, selective and transsplenic artery embolization (TSAE) by interventional technique reduced promptly the flow velocity of portal vein from 60–70 cm/s to 20 cm/s. Serum total bilirubin level decreased from 242 μmol/L to 69.7umol/L by 2 weeks and to 30.2 μmol/L at 1 month after TSAE; the daily ascites fluid volume decreased dramatically to less than 500 mL 2 weeks after TSAE. We suggest that selective splenic artery embolization is a technically simple procedure for the treatment of portal overperfusion injury in SFSS. LuNan Yan ZheYu Chen Wentao Wang Wusheng Lu Qiang Lu Weixia Cheng Tianfu Wen Mingqing Xu Jiayin Yang Liver Transplantation Division Department of Surgery West China Hospital Sichuan University Medical School Chengdu, China

The small-for-size syndrome in living donor liver transplantation: current management

Advances in small-for-size syndrome

Small-For-Size Syndrome and Graft Inflow Modulation Techniques in Liver Transplantation

Current Status of Small-for-size Syndrome

Post Living Donor Liver Transplantation Small-for-size Syndrome: Definitions, Timelines, Biochemical, and Clinical Factors for Diagnosis: Guidelines From the ILTS-iLDLT-LTSI Consensus Conference

Small-for-size syndrome in a 9.7 kg pediatric recipient with a whole liver graft

Impact of small-for-size liver grafts on medium-term and long-term graft survival in living donor liver transplantation: A meta-analysis

Conceptual changes in small-for-size graft and small-for-size syndrome in living donor liver transplantation

Outcome of Patients Undergoing Right Lobe Living Donor Liver Transplantation with Small-for-size Grafts

Small-For-Size Syndrome after Living Donor Liver Transplantation: Successful Treatment with A Transjugular Intrahepatic Portosystemic Shunt

Risk Factors of SFSS in Adult-to-Adult Living Donor Liver Transplantation Using the Right Liver: A Single-Center Analysis of 217 Cases

Clinical Significance of Grade A Small-for-size Syndrome After Living Donor Liver Transplantation Utilizing the New Definition of Diagnostic Criteria: An International Multicenter Study

Role of vascular reconstruction in the prevention of small-for-size syndrome after living donor liver transplantation

A Novel Strategy for Preventing Posttransplant Large-For-Size Syndrome in Adult Liver Transplant Recipients: A Pilot Study

Monitoring and modulation of the portal vein flow for preventing the small—for—size syndrome after living donor livertransplantation

Outcome of using small-for-size grafts in living donor liver transplantation recipients with high model for end-stage liver disease scores: a single center experience.

Left hepatectomy versus right hepatectomy for living donor liver transplantation: Shifting the risk from the donor to the recipient

Prevent Small-For-Size Syndrome Using Dual Grafts in Living Donor Liver Transplantation

Successful Treatment with Selective and Transplenic Artery Embolization for Small-for-size Syndrome: a Case Report.

Small-for-size Syndrome Secondary to Outflow Block of the Segments V and VIII Anastomoses--successful Treatment with Trans-Splenic Artery Embolization: a Case Report.

Graft inflow modulation in recipients with portal hypertension